Lupin obtains FDA approval, tentative OK for 2 genericsThe Food and Drug Administration approved Lupin’s sevelamer carbonate for oral suspension and gave tentative approval for azilsartan medoxomil tablets. ParaPro offers Natroba for new indicationNatroba provides a topical treatment for scabies infestations in adult and pediatric patients four years of age and older. AbbVie obtains FDA nod for new indication of Rinvoq Rinvoq is now approved for the treatment of moderate to severe atopic dermatitis in adults and children aged 12 years old and older whose disease did not respond to previous treatment. How Hayat Pharmacy is making connections for patients needing mental health care Hayat Pharmacy, a Health Mart Pharmacy in Milwaukee, is creating patient relationships in a diverse community via its mental health services. U.S. Court of Appeals for the Federal Circuit upholds validity of Novartis’ Gilenya dosage regimen patent Novartis said it expects no generic versions of Gilenya in the U.S. market for at least the next two years. Par launches generic Cuvposa The product is indicated to reduce chronic severe drooling in children ages 3 to 16 years old with neurologic conditions that cause abnormal drooling. Alembic given FDA OK for generic Doryx Doxycycline hyclate delayed-release tablets have a market value of roughly $10 million for the 12 months ending September 2021, according to IQVIA. Amneal to acquire Saol Therapeutics’ Baclofen franchise The acquisition expands Amneal’s neurology presence into spasticity. ViiV Healthcare receives FDA OK for Apretude Apretude is the first and only long-acting injectable option for HIV prevention, the company said. Teva debuts generic Narcan Teva’s generic Narcan provides a treatment for opioid emergencies. First Previous 132 133 134 135 136 Next Last
